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Abstract
Background: Normal tissue toxicity is the dose-limiting side effect of radiotherapy. Spatial fractionation irradiation
techniques, like microbeam radiotherapy (MRT), have shown promising results in sparing the normal brain tissue.
Most MRT studies have been conducted at synchrotron facilities. With the aim to make this promising treatment
more available, we have built the first desktop image-guided MRT device based on carbon nanotube x-ray
technology. In the current study, our purpose was to evaluate the effects of MRT on the rodent normal brain tissue
using our device and compare it with the effect of the integrated equivalent homogenous dose.
Methods: Twenty-four, 8-week-old male C57BL/6 J mice were randomly assigned to three groups: MRT, broad-beam (BB)
and sham. The hippocampal region was irradiated with two parallel microbeams in the MRT group (beam
width = 300 μm, center-to-center = 900 μm, 160 kVp). The BB group received the equivalent integral dose in the same
area of their brain. Rotarod, marble burying and open-field activity tests were done pre- and every month post-irradiation
up until 8 months to evaluate the cognitive changes and potential irradiation side effects on normal brain tissue. The
open-field activity test was substituted by Barnes maze test at 8th month. A multilevel model, random coefficients
approach was used to evaluate the longitudinal and temporal differences among treatment groups.
Results: We found significant differences between BB group as compared to the microbeam-treated and sham mice in
the number of buried marble and duration of the locomotion around the open-field arena than shams. Barnes maze
revealed that BB mice had a lower capacity for spatial learning than MRT and shams. Mice in the BB group tend to gain
weight at the slower pace than shams. No meaningful differences were found between MRT and sham up until 8-month
follow-up using our measurements.
Conclusions: Applying MRT with our newly developed prototype compact CNT-based image-guided MRT system
utilizing the current irradiation protocol can better preserve the integrity of normal brain tissue. Consequently, it enables
applying higher irradiation dose that promises better tumor control. Further studies are required to evaluate the full
extent effects of this novel modality.
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Background
Annually, approximately 200,000 new cases of malignant
brain tumors are diagnosed in the US alone [1, 2].
Radiotherapy (RT) has remained an important treatment
modality for intracranial tumors despite the inevitable
normal tissue toxicity, which is the primary reason for
dose limitations. As treatment modalities have improved,
patients live long enough to experience radiation-
induced brain injury [3, 4]. Accordingly, the American
Cancer Society has stressed that future research should
focus on reducing the complications of radiotherapy to
maximize the quality of life for patients after treatment
[4]. Microbeam radiation therapy (MRT) is a promising
pre-clinical approach in spatially fractionated RT, which
delivers quasi-parallel submillimeter lines of high-dose
irradiation (beams) that are separated by wider non-
irradiated regions (valleys). The majority of MRT studies
have been limited to synchrotron facilities. However,
aside from the sparseness of these facilities, the lack of
specialized hospitals near them has also severely hin-
dered the translation of this promising treatment ap-
proach to millions of patients around the world.
To make this technology more available for preclinical
biomedical studies, we have developed the first desktop
MRT device based on the spatially distributed carbon
nanotube x-ray technology (CNT) [5], which enables de-
livering a high dose of radiation in a laboratory setting.
Our system uses multiple concurrently activated cold
cathodes sources arranged in a line. By distributing the
electron beam along a very long and narrow line on the
anode instead of a single point, significantly better heat
conduction and therefore, higher dose delivery rates can
be achieved as compared to conventional point-focused
X-ray tubes. Furthermore, the radiation can be readily
gated with physiological signals during irradiation [6].
Nowadays, using current radiation approaches, acute
(days to weeks after irradiation) and subacute (1–
6 months post-irradiation) radiation-induced brain injur-
ies are rare and reversible, while the delayed injuries
(6 months to 1-year post-irradiation) are irreversible and
progressive [7]. In addition, the volume of normal brain
that is irradiated (the field size) is an important toxicity
determinant. Most of the studies on the effect of MRT
on normal brain tissue are focused on the short time
outcome after whole- or one-hemisphere-brain MRT
[8–10]. Consequently, more recently, many groups, in-
cluding Smyth et al. [11], have emphasized the import-
ance of evaluating chronic irradiation-induced changes
by MRT treatment on a confined area of the brain. In
the previous studies, we found that applying image-
guided MRT using our novel method was able to induce
tumor control in intracranial murine tumor model, with-
out causing any significant histological changes up to
30 days post-irradiation [12, 13]. However, our histology
evaluations indicated that BB might cause more normal
brain tissue damage than MRT in later time-points [13].
Consequently, we hypothesized that applying image-
guided MRT using our novel method would elicit less
neurocognitive impairment than equivalent BB irradi-
ation in long-term follow-up. Here, our goal was to
evaluate the potential effects of MRT on normal brain
tissue and compare it with conventional broad beam
(BB) post-irradiation in acute, subacute and more im-
portantly, the chronic time intervals.
Methods
Animals
Four-weeks-old male C57BL/6 J mice (Jackson Labora-
tory, Bar Harbor, ME) were acquired and allowed to ac-
climate for a week before study initiation.
The mice were housed in the University of North Carolina
at Chapel Hill (UNC-CH) Division of Laboratory Animal
Medicine (DLAM) pathogen free designated environment
and cared for in accordance with the United States Depart-
ment of Health and Human Services Guide for the Care
and Use of Laboratory Animals; all procedures were ap-
proved by UNC-CH Institutional Animal Care and Use
Committee (IACUC). Mice were housed in a temperature
and light-controlled environment with 12-h light/dark cycle
(lights on at 7 AM) and provided food and water.
Irradiation
Mice were randomly assigned to three treatment groups:
microbeam radiotherapy, broad-beam radiotherapy and
sham. All the mice underwent treatment at eight weeks
old under anesthesia with 1–2.5% isoflurane in medical-
grade oxygen at 0.8–1 L/min flow rate. All mice kept
anesthetized for an equal duration of time (two hours)
to normalize the influence of isoflurane on behavioral
tests outcomes [14–16].
Dosimetry
GAFCHROMIC™ EBT3 (Ashland Advanced Materials,
Covington, KY, US) film was placed at the dose entrance
plane for dosimetry and evaluating the dose profiles. The
key technical features of GAFCHROMIC™ EBT3 films that
make them suitable for our purpose included the minimal
response difference over a wide photon energy range and
high spatial resolution (25 μm or higher) [17]. As a result,
several MRT studies have used these radiochromic films
for the dosimetry evaluations [5, 18–20].
The film was cross-calibrated to an ion chamber and
scanned as previously described [21, 22]. Scanned films
were processed using in-house written Matlab script (R-
2015a, The MathWorks, Inc., Natick, MA) using princi-
ples described by Borca et al. [23].
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Microbeam radiotherapy
Image-guided MRT was performed on normal mice
brains by desktop CNT-based MRT system. Image-
guided radiotherapy was conducted using the protocol
as reported previously [21]. In brief, lateral X-ray pro-
jections were taken using onboard micro-CT scanner
to locate the bregma (Fig. 1a,b). An embedded steel
bead (1/32 in. ≈ 0.8 mm) in the holder was used as
the fiducial landmark (Fig. 1a). Since the microbeam
planes intersect with the vertical plane at a slight
angle of 8 degrees (collimator angle) [22], it was cru-
cial to calculate the distance to the center of hippo-
campus from the registered images in both anterior-
posterior and superior-inferior directions (Fig. 1c,d).
After imaging, the mice were mechanically trans-
lated from the imaging to the irradiation position.
Detailed descriptions of the device and dosimetry
have been previously reported [22]. Two arrays of mi-
crobeams were delivered unidirectional along the cor-
onal plane across each mouse brain (Fig. 2e). Each
microbeam was 300 μm wide, spaced at 900 μm
center-to-center distance and the radiation field was
centered on the hippocampus (2 mm posterior and
2.5 mm inferior to bregma) (Fig. 1c,d). The peak dose
was 36 Gy and 5 Gy dose of X-ray was manually de-
posited in valley area (Fig. 1f ).
Broad-beam radiotherapy
An industrial X-ray machine (X-RAD 320, PXi, North
Branford, CT) was used for the BB irradiation. The dose
rate, after 1.5 mm aluminum, 0.25 mm copper, plus
0.75 mm tin filter, was 1.06 Gy/min at a focal surface dis-
tance of 47 cm (Fig. 2a). For BB irradiation, the hippocam-
pal area was irradiated with 10 Gy of X-ray over 2.5 mm
irradiation field, creating an integrated equivalent dose to
the MRT beams. The beam was collimated down to
10 mm wide using an industrial 4-leaf adjustable collimator
(PXi, North Branford, CT) and then further collimated to
2.5 mm using fabricated collimator out of 1.5 cm plates of
lead (Fig. 2a,b). The setting applicability was pretested and
the dose was measured using GAFCHROMIC™ EBT3 film
(Fig. 2c,d). During the experiment, the mice were posi-
tioned such that their heads were in close contact with the
fabricated collimator and stabilized using ear bars and nose
cone (Fig. 2b). The collimator was placed 1 mm anterior to
the interaural line to target hippocampus. The orientation
of beam was same as MRT (Fig. 3c-e).
Neurocognitive testing
Mice were assessed using a battery of neurocognitive
function tests at baseline and at each month after treat-
ment and weighed using a scale with the accuracy of 10
−1 g every week for the period of study. To minimize the
a b c
d e f
Fig. 1 Image-guided Microbeam Radiotherapy Method Abstract. a: Lateral radiograph of mouse head was taken to locate the bregma. The head
was stabilized using two ear-bars and teeth wire. Embed steel bead served as the fiducial marker. b: The skull outlines were sketched over the
same radiograph. The anatomical place of hippocampus is shown regarding the bregma. d: Schematic lateral view of mouse skull with a cut
along the corpus callosum at midline. The gray line demonstrates the microbeam. In our device, the microbeam planes intersect with the vertical
plane at a slight angle of 8 degrees. The center of the treatment was placed 2 mm posterior to the bregma (c) and 2.5 mm inferior to the top of
the skull [50]. e: The side (top) and top view (bottom) of mouse under irradiation. The head was fixed by ear bars and tooth wire. Gafromic EBT-3
film was placed on top of the mouse head (entrance plan) to record the beams and generate the dose profile (f)
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effects of social influences on the behavior, mice were
housed three in a cage, in which there was one member
of each group. All the experiments were performed be-
tween 9:00 am-3:00 pm during consecutive days of a
week. The baseline weight and measurements of rotarod,
open-field and marble burying were compared between
treatment groups, to make sure no baseline difference
existed among treatment groups. A pretest was per-
formed during which mice were evaluated pre-treatment
and every week up until one month and every month
post-irradiation up until three months to evaluate the
appropriate time point to perform the behavioral test
Additional file 1: Figure S1.
Rotarod
Mice were placed on a cylinder, which slowly accelerates
to a constant rotating speed. While the heads of the
mice are placed against the direction of the rotating
rods, normal mice learn to walk forward as the rod
rotating-speed increases. For each trial, revolutions per
minute (rpm) were set at an initial value of 3 and pro-
gressively increased to a maximum of 30 rpm across
5 min. In all test sessions, the time latency before the
mouse lost its balance was measured in seconds, up to
maximum 300 s.
Pre-treatment training
An accelerating rotarod (Acceler. Rota-rod (Jones &
Robertson) for mice, 7650, Ugo Basile, Varese, Italy) was
used for the acquisition of the task. For the first session,
mice were given 3 trials, with 45 s between each trial. A
second test session with 2 trials was conducted 48 h
later, to evaluate consolidation of motor learning.
Post-treatment evaluation
A similar accelerating rotarod was used for the re-
evaluation of motor coordination. For each test, mice
were given 2 trials, with 45 s between each trial.
Fig. 2 Broad-beam (BB) Irradiation Method Abstract. a: The schematic picture demonstrates the steps to collimate down the beam to 2.5 mm (d).
b: The fabricated collimator was placed in close contact with mouse head. c: The Gafchromic™ EBT-3 film attached to fabricated collimator to rec-
ord the entrance dose (d) and generate the beam profile (e)
Fig. 3 Comparison of Normal Mouse (top row) vs. Impaired One (bottom row). The white dots are the position of mouse neck (junction of head
and body) at each second during first 10 mins of open-field activity test (superimposed scatter plots are generated using idTracker [62]).
The impaired mouse spends more time at periphery (a vs. b) and did less rearing (c vs. d) and buried fewer marbles after 30 min test (e top
vs. bottom)
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Open-Field activity
Novel environment exploration, general locomotors ac-
tivity, and anxiety-related behaviors in rodents were
assessed systematically within a square 41 cm × 41 cm
Plexiglas® box. Mice were filmed during the 30 min trial.
Measures were taken of the number of the rearing (fre-
quency with which the mice stood on their hind legs)
and duration of time they spend doing locomotion and
in the central square (29 cm × 29 cm, 50% of field area)
vs. periphery in both baseline and post-treatment
assessments.
A high duration of locomotion behavior and time
spent in the central square indicate increased explor-
ation and a lower level of anxiety [24]. It had been
shown that anxiolytics administration increases explor-
ation time in the center of the open-field while stressful
stimuli decrease the number of center visits [24] (Fig.
3a-b). Open-field activity, therefore, represents a valid
measure of marked changes in “anxiety-like” behaviors
[25]. In addition, rearing frequency corresponds with
hippocampal electrical activity [26] (Fig. 3c-d).
Pre-treatment
Mice were assessed by 30 min trial in an open-field
arena, crossed by a grid of photobeams. Counts were
taken of the number of photobeams broken during the
half an hour trial either horizontally or vertically (Versa-
Max, AccuScan Instruments).
Post-treatment
Mouse activity was recorded during 30 min experiment
in the same size arena and assessed for the same param-
eters using different software (The Observer XT 10, Nol-
dus Bv, Wageningen, The Netherlands).
Marble burying
Digging is a species-specific behavior of mice. It has
been shown that hippocampal lesions markedly reduces
the number of buried marbles to the point that cages of
mice with hippocampal lesions appears to have had no
mice in them at all [27] (Fig. 3d). To quantify this behav-
ior, twenty 9/16″ (14.3 mm) black glass marbles were
placed in equally distance five row and four columns in
a 28 × 17 × 10 cm clear plastic cage, two third of which
was filled with bedding. The cages were covered thor-
oughly after putting the mice in them. The number of
buried marbles was counted after 30 min. Buried marble
was defined as the one that more than half of it was in
the bedding.
Barnes maze
During the test, a mouse was placed at the center of a
92 cm circular table around which there were 20 holes
each 5 cm along the edges. Animals escaped from a
brightly lit open arena into a small basket located under
one of the openings. The opening to place the basket
under was assigned for each mouse randomly and
remained the same all along the testing period. The
Barnes Maze platform was made in-house using mea-
surements from Sunyer et al. [28]. Printed patterned pa-
pers were placed in different places in the room as
spatial cues. Mice were tested for 7 consecutive days and
measure was the duration of time before finding the
right opening. Each test session was up until they enter
the escape box or up to 5 min. If mice were not able to
find the correct opening during the test the period, they
were gently directed toward it.
The mice were evaluated by the Barnes maze test 8-
month post-irradiation (to measure chronic effect). At
this time point, the open-field activity was not per-
formed because both tests are based on the fear of isola-
tion and being exposed in brightly lit areas, and one test
may have a negative effect on the other one’s results.
Immunohistochemistry
Brain tissues from the animal were collected at the end
of the 3rd- (pretest group) and 9th-month post treat-
ment. Whole mouse brains were fixed in formalin for
48 h, processed, embedded in paraffin, serially sectioned
at 5 μm thickness and were used for IHC.
IHC was carried in Bond the fully automated
immunostainer (Leica). Slides were dewaxed in Bond
Dewax solution (AR9222) and hydrated in Bond
Wash solution (AR9590). Hematoxylin and Eosin
(H&E) stain was done in the Autostainer XL (Leica
Biosystems Inc., Vista, CA). H&E stained slides were
digitally imaged in the Aperio ScanScope XT (Leica)
using 20× objective. The complete list of the stains
used to evaluate the histological changes 3-month
post-irradiation can be found in the Additional file 2.
Statistical analysis
Statistical analysis was performed by SAS/STAT® version
9.4 (SAS Institute Inc., Cary, North Carolina). A p-value
<0.05 was considered statistically significant. The means
of baseline values were compared using ANOVA to en-
sure there was no significance difference at baseline
among treatment groups. A multilevel model, random
coefficients approach was used to make inferences con-
cerning treatment group differences. Random coefficient
models allow simultaneous inferences at the aggregate
and individual level while accounting for correlation be-
tween subjects that arises in longitudinal studies. These
models are also more flexible than traditional ANOVA
approaches because the constraint that each subject has
the same regression coefficients is removed. Random co-
efficient models are also more powerful than standard
cross-sectional methods with appropriate multiple
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comparison controls. For each outcome, the level 1 re-
gression equation was found using the partial residual
sum of square (PRESS) statistic under 5-fold cross valid-
ation to determine the order of the polynomial fit.
Fitting the polynomial structure discovered using the
above method; we chose the order of the random effects
that would minimize BCC in the unconditional models
while yielding nonzero covariance for the highest order
term. Each random coefficient was modeled as a func-
tion of treatment group, engendering the level 2 regres-
sion equations. Interactions with treatment group and
time arising from the level 2 equations were assessed
using type 3 tests and dropped where they were not sig-
nificant. When the treatment group was found to predict
linear or higher order slope terms, regions of signifi-
cance were calculated. Tests of differences in treatment
groups were conducted where the treatment group was
found to predict intercepts only.
Results
Figure 4 demonstrates a schematic flowchart of current
study. Mice were weighted and pre-evaluated using a
series of cognitive tests and randomly assigned in three
treatment groups (see pre-irradiation Fig. 4). No signifi-
cant differences among MRT, BB and shams in any of
measurements at baseline (Table 1).
Mice brains in MRT and BB groups were irradiated
with integrated equivalent dose (irradiation phase Fig.
4). All mice in MRT and BB groups tolerated the irradi-
ation procedures well, with no specific veterinary con-
cerns. Acute skin effects (erythema, desquamation,
inflammation or epilation) were not detected in any
mice after any irradiation approach.
Histological studies [13] and pretest results (Additional file
1: Figure S1) demonstrated no measurable changes during
the acute phase post-irradiation (up until one month) and as
a result, the mice were evaluated every month post-
irradiation using a battery of test in the current study as
demonstrated in Fig. 4, post-irradiation phase.
The BB mice, whose brains were irradiated with
homogeneous 10Gy of X-ray using a 2.5 mm wide
beam, tended to gain weight at a slower rate than
MRT and non-irradiated mice. This difference became
statistically significant between BB and controls since
week 31 post-irradiation until the end of the experi-
ment (week = 42) (Fig. 5).
There was no difference in the duration of time mice
kept their balance on the rotating rod, duration of rear-
ing and duration of time mice spent in the central area
of the open-field arena by treatment group (Table 2).
The number of the buried marbles in BB was signifi-
cantly less than the control group and significantly less
Fig. 4 Method Abstract. The mice were pre-evaluated using rotarod, open-field activity and marble burying tests were randomly assigned to
three treatment groups: broad beam (BB), microbeam radiotherapy (MRT) and controls. All mice were maintained under gaseous anesthesia for
the equal duration of time. The post-irradiation evaluations were performed each month by rotarod, open-field activity and marble burying and
8-month after exposure Barnes maze test was used to evaluate the mice. All mice brains were sent for histological assessments
9-month post-irradiation
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than the MRT group at all time points for (p ≤ 0.01) and
BB mice spent less time searching around the open-field
arena (p < 0.001).
BB mice spent more time finding the right hole in the
Barnes maze test than shams in all test sessions
(p = 0.044). There were no differences between the MRT
and shams for either of these outcomes.
Interestingly, at five-month post-irradiation, a
depigmented line appeared in all BB mice at the site
of irradiation (Additional file 3: Figure S2) which
progressed until 6th month and remained the same
without any regression or progression for the dur-
ation of the study (up to 9-month post-irradiation).
In two out of eight mice in MRT group, a line of
gray hair appeared in the exit plan at the beginning
of 8-month after irradiation that stopped progres-
sion after 20 days and did not regress during next
two months.
The brain tissues of the mice were collected 4 and
9 months post-treatment in pretest and test studies,
respectively (Fig. 4 histology). No histological
changes were detected in any mice brain sample
using IHC (data not shown).
Discussion
Radiation-induced cognitive impairment is the most fre-
quent complication among long-term cancer survivors
and occurs in up to 50–90% of adult brain tumor pa-
tients who survive more than 6 months post fractionated
partial or whole brain irradiation [29–32]. In spite of ad-
equate disease control, cognitive impairment interferes
with the patients’ ability to function at their
Table 1 Pre-irradiation Evaluation of the Mice in Three Groups
Measurement P-value
Weight 0.576
Rotarod 0.365
Marble Burying 0.216
Open-field Activity Rearing 0.332
Center 0.506
Locomotion 0.241
Fig. 5 Predicted Mean of Mice Weight. The mice were weighed at their arrival to the facility and each week after irradiation. The error bars
are SD
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pretreatment levels. Multiple prior animal studies have
reported that synchrotron MRT induces less neurotox-
icity than conventional radiotherapy [33, 34]. Here, we
found that MRT using first generation CNT-based
image-guided desktop microbeam irradiator would also
cause less neurocognitive impairment than equivalent
BB irradiation. To the best of our knowledge, this is the
first time that MRT and BB radiation-induced cognitive
impairments have been investigated using such a com-
prehensive battery of behavioral assessments for a long
duration of time after irradiation.
Local irradiation of hippocampal area with 10 Gy led
to declined cognitive function in BB mice compared to
sham (See Table 2). It has been found that 8-month after
X-ray irradiation of mouse brain with 10 Gy, there was
significant inhibition in neurogenesis level at hippocam-
pus [35]. These may explain the decline in BB mice cog-
nitive level in the current study at 8th-month post-
irradiation measured using Barnes maze test.
Interestingly, no significant difference was found be-
tween MRT and shams at any time points post-
irradiation. Different studies have reported that brain
normal tissue can maintain its normal function and in-
tegrity at higher doses of X-ray in MRT than conven-
tional radiotherapy methods. Four main mechanisms
have been postulated to play crucial role in keeping the
normal tissue integrity after MRT. First, a “beneficial”
bystander effect is hypothesized to facilitate the restor-
ation of injured cells in central nervous system [36]. Sec-
ond, due to the unique spatial distribution of X-ray in
MRT, the total contact surface between highly irradiated
and damaged tissue along the beam and minimally irra-
diated valley area is increased which may allow cells in
the valley to maintain the function of the normal tissue.
Third, multiple studies revealed that normal brain macro
and microvasculature shows higher tolerance to MRT
and immature vessels like tumor neovasculature are
preferentially damaged by this method [37]. At last, re-
cently, it has been shown that a spectrum of immune re-
sponse would be evoked. While part of this response is
in favor of normal tissue damage, different immune re-
sponses are evoked in favor of tumor resolution and pre-
serve the normal tissue function [38, 39]. Interestingly,
studies have demonstrated that activated immune re-
sponses after MRT favor this latter effect [40, 41].
No acute skin effects were observed in any mouse after
broad- or micro-beam radiotherapy. In the current study,
we observed the depigmentation hair circle in all BB-
treated mice at the site of irradiation (Additional file 1:
Figure S2). Kinoshita et al. also observed the same effects
when locally irradiated C57BL/J6 mice by a single fraction
of 10 Gy [42]. Microbeam radiation therapy utilizes rela-
tively low beam energies to keep the spatial fractionation
deep in the tissue (an anode voltage energy of 160 kVp
was used in the present study), which results in the lower
dose penetration than the conventional radiotherapy. As a
consequence, a significantly higher dose to the skin’s sur-
face needs to be applied during MRT to ensure an ad-
equate dose delivery to the target tissue. Paradoxically, in
multiple microbeam therapy studies higher than normal
tolerance of normal skin tissue has been observed [11, 43].
Interestingly, a line of gray hair appeared in two mice in
MRT group at the exit plan 8-month after X-ray expos-
ure (See Additional file 3). Previous studies have shown
that skin effects are more severe at the joint places like ax-
illa, groin and toes where the skin is subject to friction, or
has folds in its surface [44]. Since this line coincides with
the junction of mouse head and neck, we hypothesized
that this effect may be due to the constant motion of these
tissues with the associated inflammation.
No significant histological differences were detected 4-
and 9-month post-irradiation based on light microscopy
level (data not shown). While some hypothesized that
neurocognitive changes may precede histological
changes, a growing number of studies have correlated
the radiation-induced cognitive deterioration to changes
in the subcellular and molecular level of neuronal func-
tion and plasticity, particularly hippocampal long-term
potentiation (LTP) [45]. These changes can happen even
after a modest dose of X-ray (2–10 Gy) [46].
It is well established that the hippocampus plays a cru-
cial role in learning and memory and its damage leads to
various behavioral alterations including spatial learning
impairment and disturbances in fear/anxiety responses
[47, 48]. Given these critical roles and the importance of
hippocampal sparing radiotherapy in clinical applications
[49], we focused on the hippocampus as the target of
our treatment and used a radiation field size to cover
Table 2 Post-irradiation Longitudinal Neurocognitive Evaluation
Behavioral Tests Group Difference a P-value
Rotarod MRT vs. Control vs. BB 0.520
Marble Burying MRT-Control = 0.0572 0.910
MRT-BB = 1.410 0.011+
Control-BB = 1.353 0.009+
Open-field Activity Rearing MRT vs. Control vs. BB 0.180
Center MRT vs. Control vs. BB 0.510
Locomotion MRT-Control = 35.211 0.235
MRT-BB = 120.50 0.0005+
Control-BB = 85.291 0.005+
Barnes Maze MRT-Control = 3.549 0.861
MRT-BB = −36.298 0.085
Control-BB = −39.847 0.044+
+P-Value < 0.05
a The difference between predicted means are reported when there was
statistically significant difference among groups
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the whole mice hippocampus [50]. As a consequence,
our chosen behavioral tests were focused to evaluated
hippocampal-associated function (see Neurocognitive
Testing under Method).
Here, we mimicked clinical irradiation protocols, so
we applied a local low X-ray dose that we knew would
induce cognitive impairments [51], but was well below
the threshold for inducing obvious histological changes.
Due to the distinct spatial fractionation of X-ray beam in
MRT, finding the actual equivalence dose of MRT is
convoluted. Previous studies have used different assump-
tion for the physical or biological equivalent dose [41,
52]. Priyadarshika et al. suggested that the integrated
dose of MRT, which is the microbeam dose averaged
over the entire radiation volume, might be more relevant
than the peak or valley dose when compared to broad-
beam radiation [53]. In previous study, we found that
10Gy of the BB would induce same treatment efficacy as
the integrated MRT dose [13]. Accordingly, here we also
assumed that integral dose is close to actual equivalent
dose, so for MRT group an identical anatomical region
of the brain was irradiated with the equal integrated
dose.
The peak-to-valley dose ratio (PVDR) has been mea-
sured 16 at the entrance plane and decreased to 14 at
the exit plane, so the equivalent integral dose of 10Gy
BB simulated to be ≈ 46Gy in peaks [13]. But several
histological studies after high dose brain MRT have
shown a discrete band of neuronal and glial nuclei loss
only along the beam path [54–57]. This observation sup-
ports the idea that surviving cells in the valley region
play the main role in maintaining tissue function and
compensating for the loss of functional cells in the peak
region. Consequently, after microbeam irradiation, brain
toxicity is more dependent on valley region parameters
[11]. The average dose rate at the mouse brain entrance
plane has been measured to be 1.2 Gy/min. As a result,
to keep the total duration of the procedure under 2 h,
according to IACUC approved protocol, we selected a
peak X-ray dose of 35 Gy with a valley dose 5 Gy, to in-
crease the toxic effect of our method.
Our study has following limitations. The total number
of mice was limited (n = 24 in the test), but by running
pretest (n = 9 in pretest), and use of different tests on sep-
arate days, we had increased sensitivity to detecting subtle
differences. On 8th-month post-irradiation, the mice were
evaluated using Barnes Maze test, which has been found
to be the most sensitive test for detection of irradiation-
induced hippocampal-dependent cognitive changes in ro-
dent [51]. Another limitation was the use of normal mice.
Patients with brain tumors often experience cognitive dys-
function associated with the disease that is present at diag-
nosis [39, 58]. As a result, tumor regression will
substantially improve the neuropsychological function
level [59]. In the current study, the effect of two different
methods of radiotherapy on normal healthy mouse brain
was compared. Having said that, a recent study has shown
that brain tumor patients are more prone to post-
irradiation cognitive deterioration than normal patients
[60]. Consequently, the optimal study would be the one
that compares the neurocognitive of BB- and MRT-
treated brain tumor mice. However, considering the ag-
gressive nature of mice brain tumor models, such study is
not feasible for a long time follow-up.
Conclusions
We found that microbeam radiotherapy using our desk-
top device and the irradiation protocol we utilized in the
current study induced less neurocognitive impairment
than the same integrated uniform dose on the hippo-
campal area in normal mice up to 8-month post-
irradiation. Our previous studies demonstrated that ap-
plying MRT using our device is able to control the mur-
ine model of glioblastoma effectively [12]. This suggests
that another potential advantage of MRT in brain tumor
treatment is improved local tumor control rates with the
ability to apply radiobiological higher doses either by re-
irradiating of the same lesion using the same method or
combining other radiation modalities. Brain tumors are
the most common solid tumor in pediatrics [61] and
MRT seems to be a promising treatment modality for
this group of patient. Thus, in the future study, we aim
to evaluate the effect of this treatment on immature ro-
dent brain.
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